ContractSources Sought

VITAMIN C (L-ASCORBIC ACID)

DEPARTMENT OF HEALTH AND HUMAN SERVICES• 75N94025Q00021

Response Deadline

Dec 4, 2024

Deadline passed

Days Remaining

Closed

Set-Aside

Full & Open

Notice Type

Sources Sought

Contract Opportunity Analysis

The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is seeking qualified small businesses to supply C13 labeled vitamin C for metabolic research protocols. The procurement requires the delivery of 0.75g of C13 labeled vitamin C, which must meet stringent specifications including a Certificate of Analysis that confirms chemical purity, isotopic enrichment, and compliance with USP standards, with a delivery date set for March 2025. This initiative is crucial for supporting research that adheres to NIH’s clinical use standards, and interested vendors must submit a capability statement by December 4, 2024, detailing their qualifications and business size. For further inquiries, potential respondents can contact Verne L. Griffin at verne.griffin@nih.gov or Michael L. Falzone at michael.falzone@nih.gov.

Classification Codes

NAICS Code

325414

Biological Product (except Diagnostic) Manufacturing

PSC Code

6810

CHEMICALS

Solicitation Documents

1 Files

SS-75N94025Q00021.pdf

PDF•171 KB•Nov 22, 2024

AI Summary

The Eunice Kennedy Shriver National Institute of Child Health and Development (NICHD), in collaboration with the National Institute of Diabetes, Digestive, and Kidney Diseases (NIDDK), is conducting a market survey to identify qualified small businesses, including various disadvantaged groups capable of supplying C13 labeled vitamin C. This procurement aims to support metabolic research protocols requiring specific isotopes that comply with NIH’s standards for clinical use. The requirements include providing a Certificate of Analysis detailing chemical purity, isotopic enrichment, absence of animal-derived materials, and meeting USP standards, among other specifications. The product, 0.75g of C13 labeled vitamin C, is scheduled for delivery in March 2025. Interested businesses must submit a capability statement demonstrating their qualifications by December 4, 2024. Specific details, such as business size, type, and documentation confirming reseller authorization, are mandated. The notice underscores the government's rights regarding submission evaluations and clarifies that responding does not obligate the government to award a contract. This announcement targets small businesses and aims to ensure compliance with Federal Acquisition Regulations in preparing for potential procurement.